Last quarter (Q ), Sorrento Therapeutics's total revenue was $17.40M, an increase of 44.25% from the same quarter last year. In Q, Sorrento Therapeutics's net income was $-89.58M. See Sorrento Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 60.32M	$ 52.90M	$ 39.99M	$ 31.43M	$ 21.19M	$ 151.86M
Cost of Revenue	$ 22.87M	$ 13.03M	$ 9.94M	$ 12.24M	$ 7.06M	$ 3.94M
Gross Profit	$ 37.45M	$ 39.87M	$ 30.05M	$ 19.20M	$ 14.13M	$ 147.91M
Operating Expense	$ 441.00M	$ 407.92M	$ 231.57M	$ 214.38M	$ 143.61M	$ 96.47M
Operating Income	$ -403.55M	$ -368.05M	$ -201.53M	$ -195.18M	$ -129.48M	$ 51.44M
Net Non Operating Interest Income Expense	$ -9.30M	$ -10.22M	$ -20.16M	$ -35.05M	$ -56.71M	$ -4.74M
Other Income Expense	$ -116.47M	$ -84.26M	$ -88.90M	$ -129.35M	$ -27.59M	$ -31.38M
Pretax Income	$ -529.32M	$ -462.53M	$ -310.58M	$ -359.58M	$ -213.78M	$ 15.31M
Tax Provision	$ -33.66M	$ -33.52M	$ -2.01M	$ -473.00K	$ -6.27M	$ -36.04M
Earnings From Equity Interest Net Of Tax	$ 154.00K	$ -126.00K	$ -5.84M	$ -3.91M	$ -5.02M	$ -40.24M
Net Income Common Stockholders	$ -493.57M	$ -428.32M	$ -298.46M	$ -292.07M	$ -203.54M	$ 9.13M
Basic EPS	$ -1.33	$ -1.45	$ -1.30	$ -2.20	$ -1.92	$ 0.13
Diluted EPS	$ -1.33	$ -1.45	$ -1.30	$ -2.35	$ -1.92	$ 0.13
Basic Average Shares	$ 1.50B	$ 294.77M	$ 229.82M	$ 132.73M	$ 106.15M	$ 69.74M
Diluted Average Shares	$ 1.50B	$ 294.77M	$ 229.82M	$ 140.51M	$ 106.15M	$ 70.38M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 463.87M	$ 420.95M	$ 241.51M	$ 226.61M	$ 150.67M	$ 100.42M
Net Income From Continuing And Discontinued Operation	$ -493.57M	$ -428.32M	$ -298.46M	$ -292.07M	$ -203.54M	$ 9.13M
Normalized Income	$ -389.52M	$ -376.02M	$ -211.51M	$ -163.09M	$ -176.90M	$ 27.96M
Interest Expense	$ 9.30M	$ 10.22M	$ 20.16M	$ 36.14M	$ 57.63M	$ 4.98M
EBIT	$ -520.02M	$ -452.30M	$ -290.42M	$ -323.44M	$ -156.15M	$ 20.30M
EBITDA	$ -507.27M	$ -439.84M	$ -279.42M	$ -312.45M	$ -146.66M	$ 27.43M

Currency in USD

Sorrento Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing